As science learns more about how the brain works, and fails to work, t
he possibility for developing ''cognition enhancers'' becomes more pla
usible. And the demand for drugs that can help us think faster, rememb
er more, and focus more keenly has already been demonstrated by the ma
rket success of drugs like ritalin, which tames the attention span, an
d Prozac, which ups the competitive edge. The new drug Aricept, which
improves memory, more likely will join them. Whether such drugs are go
od for individuals, or for society, is an open question, one that dema
nds far more public discussion.